ONCOGENE CANCER RESEARCH
Our mission is to increase the life expectancy & quality of life for people with oncogene-driven lung cancers - like ALK, EGFR, RET, ROS1 and others. We empower patients with info, represent the patient voice & fundraise for medical research - all aimed at extending life expectancies and finding cures for these cancers. And finally, we provide grants and donations to research institutions.
Objects
THE PRESERVATION AND PROTECTION OF GOOD HEALTH BY;• SUPPORTING RESEARCH INTO THE NATURE, CAUSES, DIAGNOSIS, PREVENTION, TREATMENT AND CURE OF ONCOGENE-DRIVEN CANCERS SUCH AS ANAPLASTIC LYMPHOMA KINASE POSITIVE (ALK), EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), KRISTEN RAT SARCOMA (KRAS) AND OTHER ONCOGENE-DRIVEN CANCERS THAT TEND TO ORIGINATE IN THE LUNGS• SUPPORTING THOSE AFFECTED BY THESE CONDITIONS AND THEIR FAMILIES BY RAISING FUNDS AND WORKING WITH PHARMACEUTICAL COMPANIES, MEDICAL PROFESSIONALS, RESEARCHERS/RESEARCH BODIES, OTHER RELATED CHARITABLE TRUSTS AND ORGANISATIONS TO IMPROVE TREATMENT AND CARE OPTIONS AND TO MEET THE CHARITY’S OBJECTS
Financial health, per its FY2025 accounts
The accounts state that the charity generated a surplus of £58,288 for the year ended 5 April 2025, with unrestricted net assets of the same amount. The filing notes that the charity is exempt from audit under the small companies regime and has no paid staff or fixed assets. Trustees were unpaid, and related party expenditures were not sought for repayment.
What the accounts disclose
“Support came in many forms: friends ran the 2024 Paris Marathon, ran a 10k, took on a Tough Mudder, completed a Hyrox competition, dedicated birthday fundraisers, and donated wedding and inheritance gifts. A supporter secured a large gift from his employer, and our co-founders donated honoraria, while OCR received honoraria for advisory board participation. Passive donations from our supporters’ use of EasyFundraising also contributed.”
“Jan Clark and Yvonne Diaz incurred some expenditure on IT equipment, web domains and travel on behalf of the C I O and operate from home but are not seeking repayment and these sums are not accrued. No wages were paid in the period nor sought.” — page 23
Policies the charity declares
- Investing charity funds policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 05/04/2025
- Volunteers: 8
- Grant-making is its main activity
Funders the charity credits
- Axis Twelve
Trustees
- Yvonne Diazchair
- Angela Tyre
- Helen Tankard
- Janet Claire Clark
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 05/04/2025 | £59k | £624 |
Common questions
Is ONCOGENE CANCER RESEARCH financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated a surplus of £58,288 for the year ended 5 April 2025, with unrestricted net assets of the same amount. The filing notes that the charity is exempt from audit under the small companies regime and has no paid staff or fixed assets. Trustees were unpaid, and related party expenditures were not sought for repayment.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE DWF FOUNDATION | 2 | £5k |
| THE BEAVERBROOKS CHARITABLE TRUST | 1 | £10k |
| PINK RIBBON FOUNDATION | 1 | £3k |
| COL-RENO LIMITED | 1 | £3k |
| THE ROTHLEY TRUST | 1 | £2k |
Charities like this
- RESEARCH ALK+ UK
- ALK POSITIVE LUNG CANCER (UK)
- ABOVE & BEYOND CANCER FOUNDATION
- THE ORANGE FOUNDATION
- FIGHTING ALL CANCERS TOGETHER
- BLOOD CANCER ALLIANCE
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| ONCOGENE CANCER RESEARCH | £59k | — | 0 | unclear | — | no doubt |
| RESEARCH ALK+ UK | £34k | — | 0 | unclear | — | no doubt |
| ALK POSITIVE LUNG CANCER (UK) | £274k | — | — | unclear | — | no doubt |
| ABOVE & BEYOND CANCER FOUNDATION | £82k | — | 0 | unclear | — | no doubt |
| THE ORANGE FOUNDATION | £60k | — | — | unclear | — | no doubt |
| FIGHTING ALL CANCERS TOGETHER | £554k | — | 0 | below | — | no doubt |